Psoriasis Treatment Market 2027 | Global Size, Growth Factor, Share, Trends and Top Companies, Covid-19 Impact and Forecast Research Report



Rising prevalence of psoriasis around the world is driving the global psoriasis treatment market, says Fortune Business Insights in its recent report. The report is titled “Psoriasis Treatment Market: Global market analysis, information and forecast, 2018 – 2025. ”According to the report, the market will reach US $ 37,634.2 million by 2026, up from US $ 18,378.0 million in 2018, showing a CAGR by 8.2% between 2018 and 2026.

The research report presents a comprehensive study of the Psoriasis Treatment market leaders with key statistics such as sales, revenue, price, product image and specifications, contact details, cost, capacity, production and company profile. The report offers critical information on the state of the business. Marketing channels and market development trends are also well featured in the report, making it a valuable source of information and path for agencies and individuals.

Key stakeholders:

  • Raw material suppliers
  • Distributors / traders / wholesalers / suppliers
  • Regulators, including government agencies and NGOs
  • Commercial research and development (R&D) institutions
  • Importers and exporters
  • Government agencies, research organizations and consulting firms
  • Professional associations and industry organizations
  • End use industries

Request a sample copy of the research report:

North America will continue to dominate the market with rapid adoption of biological therapy

Fortune Business Insights predicts that the global psoriasis market will witness the dominance of North America, followed by Europe. According to the National Psoriasis Foundation, approximately 8 million people in America live with psoriasis. Due to its rapid rate of adoption of biologic therapies and increasing investment in research and development for clinical trials, North America is also expected to continue to dominate the global psoriasis market during the period. forecast.

On the other hand, the emerging markets of the Middle East and Africa, Latin America and Asia-Pacific are expected to offer lucrative growth opportunities due to a large patient base, improving health infrastructure and medical facilities; growing awareness and increasing investment in the development of new therapies for psoriasis.

The Major Players operating in the Psoriasis Treatment market are:

  • Merck & Co., Inc.,
  • LEO Pharma A / S,
  • Pfizer Inc.,
  • Sun Pharmaceutical Industries Ltd,
  • AbbVie Inc.,
  • UCB SA,
  • Amgen Inc.,
  • Johnson & Johnson Services, Inc.,
  • Eli Lilly and company,

Do you have a question ? Ask our experts:

Increased investment in the development of biologics for treatment will increase growth

The World Health Organization predicts that the frequency of psoriasis will range from 0.09% to 11.0% in all countries, making it a serious problem worldwide. The increasing prevalence of this disease is a major growth driver of the psoriasis treatment market. In addition to this, the advent of new biologics for the treatment of various diseases is also expected to give momentum to the market. Product development, clinical trials and innovation to cure this noncommunicable disease should bode well for the market.

On the negative side, lack of consensus on treatment results, expensive products, and delays in diagnostic procedures can significantly hamper the market over the years of forecasting. This, together with the delays associated with clinical management, can also hamper the overall size of the market.

Market segmentation :

By drug class

  • TNF inhibitors
  • Interleukins
  • Others

By type

  • Plaque psoriasis
  • Psoriatic arthritis
  • Others

By route of administration

By distribution channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By geography

  • North America (United States and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia and the rest of Asia-Pacific)
  • Latin America (Brazil, Mexico and the rest of Latin America)
  • Middle East and Africa (South Africa, GCC and rest of Middle East and Africa)

For more information on analyzing this report, visit:

FDA Approvals for Clinical Trials – Key Player Goal

Companies engage in clinical trials, research and development and other innovative ideas and invest heavily in them to stand out in the competition. They are also focused on obtaining clinical approvals from the Food and Drug Administration (FDA) which will add even more revenue to the market.

Main developments in the Psoriasis treatment The contract includes:

February 2019 – The FDA has approved the use of TREMFYA, an injector that can be controlled by the patient alone by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson Services Inc., for the treatment of severe and moderate cases of psoriasis..

April 2019 – Duobrii, the first and only lotion for adults with psoriasis, manufactured by Ortho Dermatlogics, has received FDA approval.

Reasons to buy this report:

  • Monitors developments, such as new product launches, agreements, mergers and acquisitions, geographic expansions and joint ventures.
  • Comprehensive analysis of Aesthetic Implants market growth drivers, obstacles, opportunities, and other related challenges.
  • Identifies constraints and market boosters.
  • Identifies all possible segments present in the market to help organizations in strategic business planning.

About Us:

Fortune Business Insights â„¢ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions to our clients, helping them meet the specific challenges of their businesses. Our goal is to provide our clients with comprehensive market information, giving them a granular overview of the market in which they operate.

Our reports contain a unique blend of tangible information and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use cutting-edge research tools and techniques to compile comprehensive market research, interspersed with relevant data.

At Fortune Business Insights â„¢, we aim to highlight the most lucrative growth opportunities for our clients. We therefore offer recommendations allowing them to navigate more easily in technological and market-related developments. Our consulting services are designed to help organizations identify hidden opportunities and understand dominant competitive challenges.

Contact us:

Fortune Business Insights â„¢ Pvt. Ltd.

308, Supreme Headquarters,

Investigation n ° 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


United States: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

E-mail:[email protected]

Fortune Business Insights â„¢

Linkedin | Twitter | Blogs


Leave A Reply

Your email address will not be published.